Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)

Clinical trial NCT02204904 · TERMINATED

Trial details

NCT number: NCT02204904
Sponsor: Genetix Biotherapeutics Inc.
Status: TERMINATED
Study type: OBSERVATIONAL

X-Linked Adrenoleukodystrophy (X-ALD)Cerebral Adrenoleukodystrophy (CALD)Adrenoleukodystrophy (ALD)

Start date: 2015-04-01
Primary completion: 2019-12-06
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.